Functional Analysis of p53 Binding under Differential Stresses

REFERENCES

• Adimoolam, S., and J. M. Ford. 2002. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. USA 99:12985–12990.
   PubMed Web of Science ®Google Scholar
• Alarcon, R., C. Koumenis, R. K. Geyer, C. G. Maki, and A. J. Giaccia. 1999. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res. 59:6046–6051.
   PubMed Web of Science ®Google Scholar
• Alders, M., A. Ryan, M. Hodges, J. Bliek, A. P. Feinberg, O. Privitera, A. Westerveld, P. F. Little, and M. Mannens. 2000. Disruption of a novel imprinted zinc-finger gene, ZNF215, in Beckwith-Wiedemann syndrome. Am. J. Hum. Genet. 66:1473–1484.
   PubMedGoogle Scholar
• Allison, S. J., and J. Milner. 2004. Remodelling chromatin on a global scale: a novel protective function of p53. Carcinogenesis 25:1551–1557.
   PubMed Web of Science ®Google Scholar
• Amundson, S. A., M. Bittner, Y. Chen, J. Trent, P. Meltzer, and A. J. Fornace, Jr. 1999. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18:3666–3672.
   PubMed Web of Science ®Google Scholar
• Antequera, F., and A. Bird. 1993. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA 90:11995–11999.
   PubMed Web of Science ®Google Scholar
• Brown, J. M., and A. J. Giaccia. 1998. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58:1408–1416.
   PubMed Web of Science ®Google Scholar
• Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942.
   PubMed Web of Science ®Google Scholar
• Cawley, S., S. Bekiranov, H. H. Ng, P. Kapranov, E. A. Sekinger, D. Kampa, A. Piccolboni, V. Sementchenko, J. Cheng, A. J. Williams, R. Wheeler, B. Wong, J. Drenkow, M. Yamanaka, S. Patel, S. Brubaker, H. Tammana, G. Helt, K. Struhl, and T. R. Gingeras. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499–509.
   PubMed Web of Science ®Google Scholar
• Ceribelli, M., M. Alcalay, M. A. Vigano, and R. Mantovani. 2006. Repression of new p53 targets revealed by ChIP on chip experiments. Cell Cycle 5:1102–1110.
   PubMed Web of Science ®Google Scholar
• Craig, J. M., and W. A. Bickmore. 1994. The distribution of CpG islands in mammalian chromosomes. Nat. Genet. 7:376–382.
   PubMed Web of Science ®Google Scholar
• Cross, S. H., V. H. Clark, M. W. Simmen, W. A. Bickmore, H. Maroon, C. F. Langford, N. P. Carter, and A. P. Bird. 2000. CpG island libraries from human chromosomes 18 and 22: landmarks for novel genes. Mamm. Genome 11:373–383.
   PubMedGoogle Scholar
• el-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45–49.
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Forsythe, J. A., B. H. Jiang, N. V. Iyer, F. Agani, S. W. Leung, R. D. Koos, and G. L. Semenza. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604–4613.
   PubMed Web of Science ®Google Scholar
• Gassmann, R., A. Carvalho, A. J. Henzing, S. Ruchaud, D. F. Hudson, R. Honda, E. A. Nigg, D. L. Gerloff, and W. C. Earnshaw. 2004. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 166:179–191.
   PubMed Web of Science ®Google Scholar
• Giaccia, A. J., and M. B. Kastan. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973–2983.
   PubMed Web of Science ®Google Scholar
• Gibbs, P. E., W. G. McGregor, V. M. Maher, P. Nisson, and C. W. Lawrence. 1998. A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc. Natl. Acad. Sci. USA 95:6876–6880.
   PubMedGoogle Scholar
• Graeber, T. G., C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88–91.
   PubMed Web of Science ®Google Scholar
• Graeber, T. G., J. F. Peterson, M. Tsai, K. Monica, A. J. Fornace, Jr., and A. J. Giaccia. 1994. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264–6277.
   PubMed Web of Science ®Google Scholar
• Grandori, C., S. M. Cowley, L. P. James, and R. N. Eisenman. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:653–699.
   PubMed Web of Science ®Google Scholar
• Hammond, E. M., D. J. Mandell, A. Salim, A. J. Krieg, T. M. Johnson, H. A. Shirazi, L. D. Attardi, and A. J. Giaccia. 2006. Genome-wide analysis of p53 under hypoxic conditions. Mol. Cell. Biol. 26:3492–3504.
   PubMed Web of Science ®Google Scholar
• Hammond, E. M., N. C. Denko, M. J. Dorie, R. T. Abraham, and A. J. Giaccia. 2002. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 22:1834–1843.
   PubMed Web of Science ®Google Scholar
• Hammond, E. M., and A. J. Giaccia. 2005. The role of p53 in hypoxia-induced apoptosis. Biochem. Biophys. Res. Commun. 331:718–725.
   PubMed Web of Science ®Google Scholar
• Hammond, E. M., S. L. Green, and A. J. Giaccia. 2003. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutat. Res. 532:205–213.
   PubMed Web of Science ®Google Scholar
• Harms, K., S. Nozell, and X. Chen. 2004. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61:822–842.
   PubMed Web of Science ®Google Scholar
• Hearnes, J. M., D. J. Mays, K. L. Schavolt, L. Tang, X. Jiang, and J. A. Pietenpol. 2005. Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators. Mol. Cell. Biol. 25:10148–10158.
   PubMed Web of Science ®Google Scholar
• Heisler, L. E., D. Torti, P. C. Boutros, J. Watson, C. Chan, N. Winegarden, M. Takahashi, P. Yau, T. H. Huang, P. J. Farnham, I. Jurisica, J. R. Woodgett, R. Bremner, L. Z. Penn, and S. D. Der. 2005. CpG island microarray probe sequences derived from a physical library are representative of CpG islands annotated on the human genome. Nucleic Acids Res. 33:2952–2961.
   PubMed Web of Science ®Google Scholar
• Ho, J., and S. Benchimol. 2003. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ. 10:404–408.
   PubMed Web of Science ®Google Scholar
• Ho, J. S., W. Ma, D. Y. Mao, and S. Benchimol. 2005. p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol. Cell. Biol. 25:7423–7431.
   PubMed Web of Science ®Google Scholar
• Hoffman, W. H., S. Biade, J. T. Zilfou, J. Chen, and M. Murphy. 2002. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J. Biol. Chem. 277:3247–3257.
   PubMed Web of Science ®Google Scholar
• Hwang, B. J., J. M. Ford, P. C. Hanawalt, and G. Chu. 1999. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA 96:424–428.
   PubMed Web of Science ®Google Scholar
• Imbriano, C., A. Gurtner, F. Cocchiarella, S. Di Agostino, V. Basile, M. Gostissa, M. Dobbelstein, G. Del Sal, G. Piaggio, and R. Mantovani. 2005. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol. Cell. Biol. 25:3737–3751.
   PubMed Web of Science ®Google Scholar
• Jakacka, M., M. Ito, F. Martinson, T. Ishikawa, E. J. Lee, and J. L. Jameson. 2002. An estrogen receptor (ER) alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16:2188–2201.
   PubMed Web of Science ®Google Scholar
• Jakacka, M., M. Ito, J. Weiss, P. Y. Chien, B. D. Gehm, and J. L. Jameson. 2001. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J. Biol. Chem. 276:13615–13621.
   PubMed Web of Science ®Google Scholar
• Jen, K. Y., and V. G. Cheung. 2005. Identification of novel p53 target genes in ionizing radiation response. Cancer Res. 65:7666–7673.
   PubMedGoogle Scholar
• Johnson, T. M., E. M. Hammond, A. Giaccia, and L. D. Attardi. 2005. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality. Nat. Genet. 37:145–152.
   PubMed Web of Science ®Google Scholar
• Kaneko, M., M. Ishiguro, Y. Niinuma, M. Uesugi, and Y. Nomura. 2002. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 532:147–152.
   PubMed Web of Science ®Google Scholar
• Kikkert, M., R. Doolman, M. Dai, R. Avner, G. Hassink, S. van Voorden, S. Thanedar, J. Roitelman, V. Chau, and E. Wiertz. 2004. Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 279:3525–3534.
   PubMed Web of Science ®Google Scholar
• Kirmizis, A., S. M. Bartley, A. Kuzmichev, R. Margueron, D. Reinberg, R. Green, and P. J. Farnham. 2004. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18:1592–1605.
   PubMed Web of Science ®Google Scholar
• Kolehmainen, J., G. C. Black, A. Saarinen, K. Chandler, J. Clayton-Smith, A. L. Traskelin, R. Perveen, S. Kivitie-Kallio, R. Norio, M. Warburg, J. P. Fryns, A. de la Chapelle, and A. E. Lehesjoki. 2003. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am. J. Hum. Genet. 72:1359–1369.
   PubMed Web of Science ®Google Scholar
• Koshiji, M., Y. Kageyama, E. A. Pete, I. Horikawa, J. C. Barrett, and L. E. Huang. 2004. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23:1949–1956.
   PubMed Web of Science ®Google Scholar
• Koumenis, C., R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, Y. Taya, S. W. Lowe, M. Kastan, and A. Giaccia. 2001. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 21:1297–1310.
   PubMed Web of Science ®Google Scholar
• Krieg, A. J., S. A. Krieg, B. S. Ahn, and D. J. Shapiro. 2004. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J. Biol. Chem. 279:5025–5034.
   PubMedGoogle Scholar
• Kzhyshkowska, J., A. Rusch, H. Wolf, and T. Dobner. 2003. Regulation of transcription by the heterogeneous nuclear ribonucleoprotein E1B-AP5 is mediated by complex formation with the novel bromodomain-containing protein BRD7. Biochem. J. 371:385–393.
   PubMedGoogle Scholar
• Laganiere, J., G. Deblois, C. Lefebvre, A. R. Bataille, F. Robert, and V. Giguere. 2005. From the cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102:11651–11656.
   PubMed Web of Science ®Google Scholar
• Lee, S., B. Elenbaas, A. Levine, and J. Griffith. 1995. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013–1020.
   PubMed Web of Science ®Google Scholar
• Li, Z., H. Zhang, T. P. McManus, J. J. McCormick, C. W. Lawrence, and V. M. Maher. 2002. hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts. Mutat. Res. 510:71–80.
   PubMedGoogle Scholar
• Lin, X., K. Ramamurthi, M. Mishima, A. Kondo, R. D. Christen, and S. B. Howell. 2001. p53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res. 61:1508–1516.
   PubMed Web of Science ®Google Scholar
• Lin, X., J. Trang, T. Okuda, and S. B. Howell. 2006. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Clin. Cancer Res. 12:563–568.
   PubMedGoogle Scholar
• Liu, L., and M. C. Simon. 2004. Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3:492–497.
   PubMed Web of Science ®Google Scholar
• Lomvardas, S., and D. Thanos. 2002. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110:261–271.
   PubMedGoogle Scholar
• Mao, D. Y., J. D. Watson, P. S. Yan, D. Barsyte-Lovejoy, F. Khosravi, W. W. Wong, P. J. Farnham, T. H. Huang, and L. Z. Penn. 2003. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13:882–886.
   PubMed Web of Science ®Google Scholar
• Moberg, K. H., W. A. Tyndall, and D. J. Hall. 1992. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J. Cell Biochem. 49:208–215.
   PubMed Web of Science ®Google Scholar
• Montano, M. M., B. M. Wittmann, and N. R. Bianco. 2000. Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity. J. Biol. Chem. 275:34306–34313.
   PubMedGoogle Scholar
• Murphy, M., J. Ahn, K. K. Walker, W. H. Hoffman, R. M. Evans, A. J. Levine, and D. L. George. 1999. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 13:2490–2501.
   PubMed Web of Science ®Google Scholar
• Murphy, M., A. Hinman, and A. J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10:2971–2980.
   PubMed Web of Science ®Google Scholar
• Nagao, Y., J. S. Platero, A. Waheed, and W. S. Sly. 1993. Human mitochondrial carbonic anhydrase: cDNA cloning, expression, subcellular localization, and mapping to chromosome 16. Proc. Natl. Acad. Sci. USA 90:7623–7627.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. T., K. Cho, S. A. Stratton, and M. C. Barton. 2005. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol. Cell. Biol. 25:2147–2157.
   PubMedGoogle Scholar
• Oberley, M. J., D. R. Inman, and P. J. Farnham. 2003. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J. Biol. Chem. 278:42466–42476.
   PubMedGoogle Scholar
• Oberley, M. J., J. Tsao, P. Yau, and P. J. Farnham. 2004. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 376:315–334.
   PubMedGoogle Scholar
• Orian, A., B. van Steensel, J. Delrow, H. J. Bussemaker, L. Li, T. Sawado, E. Williams, L. W. Loo, S. M. Cowley, C. Yost, S. Pierce, B. A. Edgar, S. M. Parkhurst, and R. N. Eisenman. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17:1101–1114.
   PubMed Web of Science ®Google Scholar
• Osada, M., H. L. Park, Y. Nagakawa, K. Yamashita, A. Fomenkov, M. S. Kim, G. Wu, S. Nomoto, B. Trink, and D. Sidransky. 2005. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell. Biol. 25:6077–6089.
   PubMedGoogle Scholar
• Persengiev, S. P., L. R. Devireddy, and M. R. Green. 2002. Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev. 16:1806–1814.
   PubMedGoogle Scholar
• Prakash, S., R. E. Johnson, and L. Prakash. 2005. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. Annu. Rev. Biochem. 74:317–353.
   PubMed Web of Science ®Google Scholar
• Qian, H., T. Wang, L. Naumovski, C. D. Lopez, and R. K. Brachmann. 2002. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21:7901–7911.
   PubMed Web of Science ®Google Scholar
• Rampalli, S., L. Pavithra, A. Bhatt, T. K. Kundu, and S. Chattopadhyay. 2005. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol. Cell. Biol. 25:8415–8429.
   PubMed Web of Science ®Google Scholar
• Robyr, D., A. Gegonne, A. P. Wolffe, and W. Wahli. 2000. Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin. J. Biol. Chem. 275:28291–28300.
   PubMedGoogle Scholar
• Romero-Ramirez, L., H. Cao, D. Nelson, E. Hammond, A. H. Lee, H. Yoshida, K. Mori, L. H. Glimcher, N. C. Denko, A. J. Giaccia, Q. T. Le, and A. C. Koong. 2004. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64:5943–5947.
   PubMed Web of Science ®Google Scholar
• Sasaki, Y., S. Ishida, I. Morimoto, T. Yamashita, T. Kojima, C. Kihara, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino. 2002. The p53 family member genes are involved in the Notch signal pathway. J. Biol. Chem. 277:719–724.
   PubMedGoogle Scholar
• Sengupta, S., and C. C. Harris. 2005. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6:44–55.
   PubMed Web of Science ®Google Scholar
• Shan, B., J. Xu, Y. Zhuo, C. A. Morris, and G. F. Morris. 2003. Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation. J. Biol. Chem. 278:44009–44017.
   PubMedGoogle Scholar
• Shivji, K. K., M. K. Kenny, and R. D. Wood. 1992. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 69:367–374.
   PubMed Web of Science ®Google Scholar
• Tan, M., S. Li, M. Swaroop, K. Guan, L. W. Oberley, and Y. Sun. 1999. Transcriptional activation of the human glutathione peroxidase promoter by p53. J. Biol. Chem. 274:12061–12066.
   PubMed Web of Science ®Google Scholar
• Tsuchimochi, K., N. Yagishita, S. Yamasaki, T. Amano, Y. Kato, K. Kawahara, S. Aratani, H. Fujita, F. Ji, A. Sugiura, T. Izumi, A. Sugamiya, I. Maruyama, A. Fukamizu, S. Komiya, K. Nishioka, and T. Nakajima. 2005. Identification of a crucial site for synoviolin expression. Mol. Cell. Biol. 25:7344–7356.
   PubMedGoogle Scholar
• Vaupel, P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14:198–206.
   PubMed Web of Science ®Google Scholar
• Walter, K., G. Warnecke, R. Bowater, W. Deppert, and E. Kim. 2005. Tumor suppressor p53 binds with high affinity to CTG · CAG trinucleotide repeats and induces topological alterations in mismatched duplexes. J. Biol. Chem. 280:42497–42507.
   PubMedGoogle Scholar
• Wang, L., Q. Wu, P. Qiu, A. Mirza, M. McGuirk, P. Kirschmeier, J. R. Greene, Y. Wang, C. B. Pickett, and S. Liu. 2001. Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J. Biol. Chem. 276:43604–43610.
   PubMedGoogle Scholar
• Watanabe, T., S. Inoue, H. Hiroi, A. Orimo, H. Kawashima, and M. Muramatsu. 1998. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18:442–449.
   PubMed Web of Science ®Google Scholar
• Webb, P., G. N. Lopez, R. M. Uht, and P. J. Kushner. 1995. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:443–456.
   PubMed Web of Science ®Google Scholar
• Wei, C. L., Q. Wu, V. B. Vega, K. P. Chiu, P. Ng, T. Zhang, A. Shahab, H. C. Yong, Y. Fu, Z. Weng, J. Liu, X. D. Zhao, J. L. Chew, Y. L. Lee, V. A. Kuznetsov, W. K. Sung, L. D. Miller, B. Lim, E. T. Liu, Q. Yu, H. H. Ng, and Y. Ruan. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207–219.
   PubMed Web of Science ®Google Scholar
• Weinmann, A. S., P. S. Yan, M. J. Oberley, T. H. Huang, and P. J. Farnham. 2002. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16:235–244.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D. S., S. K. Ogden, S. A. Stratton, J. L. Piechan, T. T. Nguyen, G. A. Smulian, and M. C. Barton. 2005. A direct intersection between p53 and transforming growth factor β pathways targets chromatin modification and transcription repression of the α-fetoprotein gene. Mol. Cell. Biol. 25:1200–1212.
   PubMedGoogle Scholar
• Wittschieben, J., M. K. Shivji, E. Lalani, M. A. Jacobs, F. Marini, P. J. Gearhart, I. Rosewell, G. Stamp, and R. D. Wood. 2000. Disruption of the developmentally regulated Rev3l gene causes embryonic lethality. Curr. Biol. 10:1217–1220.
   PubMedGoogle Scholar
• Wittschieben, J. P., S. C. Reshmi, S. M. Gollin, and R. D. Wood. 2006. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res. 66:134–142.
   PubMed Web of Science ®Google Scholar
• Wu, F., X. Lin, T. Okuda, and S. B. Howell. 2004. DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance. Cancer Res. 64:8029–8035.
   PubMed Web of Science ®Google Scholar
• Yang, L., T. Guan, and L. Gerace. 1997. Integral membrane proteins of the nuclear envelope are dispersed throughout the endoplasmic reticulum during mitosis. J. Cell Biol. 137:1199–1210.
   PubMed Web of Science ®Google Scholar